AiPing Pharmaceutical Strikes Ibuprofen Deal with Xinhua Pharmaceutical

Wednesday, November 28, 2018

AiPing Pharmaceutical, Inc. announced today that it has completed the sale of three ibuprofen Abbreviated New Drug Applications (ANDAs) in the U.S. to Shandong Xinhua Pharmaceutical Co., Ltd. AiPing will retain sales and distribution rights in the U.S.

“This is a key milestone in AiPing’s strategic cooperation with Shandong Xinhua to bring high-quality and affordable drugs to the U.S. market,” Daniel-Joseph Leung, Ph.D., Executive VP of AiPing, said in a statement.

“As a reliable supplier of active pharmaceutical ingredients (API) to the global market since 1990s, Shandong Xinhua looks forward to launching drug products in the U.S. market,” said Mr. Daiming Zhang, Chairman of Shandong Xinhua.

AirBridgeCargo - Air frieght solutions for your Pharma Matcon Efficently handling tablets and powders in IBC's Swiss World Cargo - Pharmaceuticals & Healthcare MECO - 90 Years